Table 2.
Correlation of high mRNA expression and patient survival outcome in multiple cancer types.
| Cancer type | Genes | Expression in tumors (p < 0.05) | Survival analysis (p < 0.05) |
|---|---|---|---|
| Ovarian | LY6D | Up | Poor prognosis |
| LY6E | Up | Poor prognosis | |
| LY6H | Up | Poor prognosis | |
| LY6K | Up | Poor prognosis | |
| Colorectal | LY6D | Up | Poor prognosis |
| LY6E | Up | Poor prognosis | |
| LY6H | Up | Poor prognosis | |
| LY6K | Up | Poor prognosis | |
| Gastric | LY6D | Up | Poor prognosis |
| LY6E | Up | Poor prognosis | |
| LY6H | Up | Poor prognosis | |
| LY6K | Up | Poor prognosis | |
| Breast | LY6D | Up | Poor prognosis |
| LY6E | Up | Poor prognosis | |
| LY6H | Up | Poor prognosis | |
| LY6K | Up | Poor prognosis | |
| Lung | LY6D | Up | Poor prognosis |
| LY6E | Up | Poor prognosis | |
| LY6H | Up | OS (NS), Others (NA) | |
| LY6K | Up | Poor prognosis | |
| Bladder | LY6D | Up | OS (NS), Others (NA) |
| LY6E | Up | Poor prognosis | |
| LY6H | NS | OS (NS), Others (NA) | |
| LY6K | Up | Poor prognosis | |
| Brain and CNS | LY6D | Up | OS (NS), Others (NA) |
| LY6E | Up | Poor prognosis | |
| LY6H | Up | OS (NS), Others (NA) | |
| LY6K | Up | Poor prognosis | |
| Cervical | LY6D | Up | OS (NA), RFS (NS) |
| LY6E | Up | OS (NA), RFS (NS) | |
| LY6H | Up | OS (NA), RFS (NS) | |
| LY6K | Up | OS (NA), RFS (NS) | |
| Esophageal | LY6D | Up | OS (NS), Others (NA) |
| LY6E | Up | OS (NS), Others (NA) | |
| LY6H | Up | OS (NS), Others (NA) | |
| LY6K | Up | OS (NS), Others (NA) | |
| Head and neck | LY6D | Up | OS (NS), Others (NA) |
| LY6E | Up | OS (NS), Others (NA) | |
| LY6H | Up | OS (NS), Others (NA) | |
| LY6K | Up | OS (NS), Others (NA) | |
| Pancreatic | LY6D | Up | OS (NS), Others (NA) |
| LY6E | Up | OS (NS), Others (NA) | |
| LY6H | Up | OS (NS), Others (NA) | |
| LY6K | Up | OS (NS), Others (NA) |